( November 11, 2024, 12:19 PM EST) -- BROOKLYN, N.Y. — Parties in a multidistrict litigation stemming from allegations that over-the-counter cough and cold medications containing the active ingredient phenylephrine XE "phenylephrine" (PE) are ineffective at relieving nasal congestion filed a letter with the New York federal judge overseeing the MDL on how a recent recommendation from the U.S. Food and Drug Administration will impact the parties’ proposed order to dismiss all cases....